FDA recall, , Moderate risk
Advagen Pharma Metoprolol Tartrate Tablets
Metoprolol Tartrate Tablets contain foreign tablets or capsules.
What happened
Advagen Pharma Limited, of East Windsor, New Jersey, is recalling 3,684 bottles of Metoprolol Tartrate Tablets, USP, 50 mg, sold in bottles of 1,000 tablets. The problem is the presence of foreign tablets or capsules in the bottles.
The company started the recall on its own on October 27, 2026, and told customers by letter. The product was distributed nationwide in the United States. The bottles are marked as prescription only. The FDA added the recall to its Enforcement Report and classified it on November 10, 2026.
What to do
If a code on your package is listed below:
- Don't stop taking it without talking to your pharmacist or doctor; ask them whether your lot is recalled.
Typical advice for a recalled medicine; the FDA notice gives no product-specific instructions.
Is yours affected?
Match the lot code and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Metoprolol Tartrate Tablets, USP
- Strength
- 50 mg
- NDC
- 72888-210-00
- Lot code
- 2611C065A1
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 9, 2026
- Sold in
Distributed nationwide.
- Recalled by
- Advagen Pharma LimitedEast Windsor, New Jersey
- Hazard
- Foreign object
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100234
- Recall number
- D-0182-2027
- Quantity recalled
- 3684 bottles
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from Advagen Pharma Limited
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Advagen Pharma began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary



